Generative AI Solutions Corp. (“GenAI” or the “Company”) (CSE: AICO) (FSE: 99L.F) (OTC: AICOF) is pleased to announce that it has signed a non-binding letter of intent on April 24, 2023 to acquire all of the outstanding securities of Global AI Billing Corp. (“Global AI Billing”) for 7.5 million common shares of GenAI (“GenAI Shares”) and the assumption by GenAI of US$1.25 million in existing liabilities of Global AI Billing (the “Proposed Transaction”). Global AI Billings primary assets include the ownership of 10% in Remitz, Inc, (“Remitz”), a medical billing provider that has developed proprietary artificial intelligence technology (“AI Billing”) to efficiently collect outstanding receivables on behalf of medical organizations in the United States.
Read the full article: GenAI Signs Non-Binding Letter of Intent to Acquire Medical AI Billing Company //
Source: https://www.prnewswire.com/news-releases/genai-signs-non-binding-letter-of-intent-to-acquire-medical-ai-billing-company-301807033.html